Renaissance Technologies’s Galmed Pharmaceuticals GLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-282
| Closed | -$16K | – | 4216 |
|
|
2022
Q3 | $16K | Buy |
282
+106
| +60% | +$6.01K | ﹤0.01% | 3918 |
|
|
2022
Q2 | $21K | Buy |
+176
| New | +$21K | ﹤0.01% | 4111 |
|
|
2021
Q2 | – | Sell |
-337
| Closed | -$208K | – | 3574 |
|
|
2021
Q1 | $208K | Sell |
337
-306
| -48% | -$189K | ﹤0.01% | 3137 |
|
|
2020
Q4 | $360K | Buy |
643
+453
| +238% | +$254K | ﹤0.01% | 2970 |
|
|
2020
Q3 | $121K | Sell |
190
-243
| -56% | -$155K | ﹤0.01% | 3184 |
|
|
2020
Q2 | $373K | Buy |
433
+210
| +94% | +$181K | ﹤0.01% | 2969 |
|
|
2020
Q1 | $139K | Sell |
223
-138
| -38% | -$86K | ﹤0.01% | 3170 |
|
|
2019
Q4 | $375K | Buy |
361
+269
| +292% | +$279K | ﹤0.01% | 2998 |
|
|
2019
Q3 | $79K | Sell |
92
-87
| -49% | -$74.7K | ﹤0.01% | 3290 |
|
|
2019
Q2 | $237K | Sell |
179
-3
| -2% | -$3.97K | ﹤0.01% | 3261 |
|
|
2019
Q1 | $268K | Sell |
182
-5
| -3% | -$7.36K | ﹤0.01% | 3130 |
|
|
2018
Q4 | $229K | Buy |
+187
| New | +$229K | ﹤0.01% | 3101 |
|
|
2018
Q2 | – | Sell |
-498
| Closed | -$500K | – | 3369 |
|
|
2018
Q1 | $500K | Buy |
498
+289
| +138% | +$290K | ﹤0.01% | 2915 |
|
|
2017
Q4 | $345K | Buy |
+209
| New | +$345K | ﹤0.01% | 2982 |
|
|
2016
Q3 | – | Sell |
-61
| Closed | -$49K | – | 3387 |
|
|
2016
Q2 | $49K | Buy |
+61
| New | +$49K | ﹤0.01% | 3234 |
|
|
2015
Q3 | – | Sell |
-60
| Closed | -$109K | – | 3230 |
|
|
2015
Q2 | $109K | Sell |
60
-34
| -36% | -$61.8K | ﹤0.01% | 3078 |
|
|
2015
Q1 | $159K | Buy |
+94
| New | +$159K | ﹤0.01% | 2936 |
|